The auto-reactivity of ERK inhibitor (hydralazine)-treated CD4+ T cells was confirmed by the finding that injection into syngeneic mice caused lupus-like symptoms, similar to the 5-aza-cytidine treatments [45]. The gene discussed is CD4; the disease is systemic lupus erythematosus.